Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “mRNA vaccine”
A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults
ClinicalTrials.gov study NCT05827926. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age
ClinicalTrials.gov study NCT04796896. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
ClinicalTrials.gov study NCT04785144. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
ClinicalTrials.gov study NCT04470427. IPD Sharing: NO. Countries: 1. Publications: 17.
A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants
ClinicalTrials.gov study NCT04860297. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
ClinicalTrials.gov study NCT06060457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old
ClinicalTrials.gov study NCT05375838. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer
ClinicalTrials.gov study NCT03480152. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
ClinicalTrials.gov study NCT04956575. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
ClinicalTrials.gov study NCT04405076. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
ClinicalTrials.gov study NCT05827068. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults
ClinicalTrials.gov study NCT03713086. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
ClinicalTrials.gov study NCT04927065. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters
ClinicalTrials.gov study NCT05137236. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Ag
ClinicalTrials.gov study NCT04652102. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)
ClinicalTrials.gov study NCT04283461. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
ClinicalTrials.gov study NCT05827978. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults
ClinicalTrials.gov study NCT05398796. IPD Sharing: NO. Countries: 1. Publications: 3.
Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults
ClinicalTrials.gov study NCT04064905. IPD Sharing: NO. Countries: 2. Publications: 1.
Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults
ClinicalTrials.gov study NCT04232280. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.